NUVL
Nuvalent Inc
NASDAQ: NUVL · HEALTHCARE · BIOTECHNOLOGY
$100.28
+1.19% today
Updated 2026-04-30
Market cap
$8.01B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-5.85
Dividend yield
—
52W range
$64 – $113
Volume
0.6M
Nuvalent Inc (NUVL) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
-12.5%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-50.5%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-2.6%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-4.0%
2025-08-07
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-04 | $-1.58 | -6.8% | $100.22 | $100.13 | -0.1% |
| 2025-10-30 | $-1.70 | -25.0% | $102.97 | $99.32 | -3.5% |
| 2025-08-07 | $-1.39 | -13.9% | $77.23 | $74.11 | -4.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-1.48 | $-1.58 | -6.8% | — | — |
| 2025-09-30 | $-1.36 | $-1.70 | -25.0% | — | — |
| 2025-06-30 | $-1.22 | $-1.39 | -13.9% | — | — |
| 2025-03-31 | $-1.13 | $-1.18 | -4.4% | — | — |
| 2024-12-31 | $-1.08 | $-1.05 | +2.8% | — | — |
| 2024-09-30 | $-0.94 | $-1.28 | -36.2% | — | — |
| 2024-06-30 | $-0.76 | $-0.88 | -15.3% | — | — |
| 2024-03-31 | $-0.68 | $-0.69 | -1.5% | — | — |
| 2023-12-31 | $-0.60 | $-0.62 | -3.3% | — | — |
| 2023-09-30 | $-0.58 | $-0.59 | -1.7% | — | — |
| 2023-06-30 | $-0.53 | $-0.51 | +3.8% | — | — |
Frequently asked questions
Has Nuvalent Inc beaten earnings estimates?
Nuvalent Inc has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports, with an average EPS surprise of -12.5% over the last 4 quarters.
How does NUVL stock react to earnings?
NUVL stock has moved an average of -2.6% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.